American National Bank boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 35.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 12,939 shares of the company’s stock after buying an additional 3,375 shares during the period. American National Bank’s holdings in Bath & Body Works were worth $485,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of BBWI. BlackRock Inc. grew its stake in shares of Bath & Body Works by 1.0% in the first quarter. BlackRock Inc. now owns 17,074,153 shares of the company’s stock valued at $624,573,000 after buying an additional 174,915 shares in the last quarter. State Street Corp grew its position in Bath & Body Works by 0.6% in the third quarter. State Street Corp now owns 10,038,767 shares of the company’s stock valued at $327,264,000 after acquiring an additional 58,201 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Bath & Body Works by 8.2% during the second quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company’s stock valued at $171,326,000 after purchasing an additional 484,674 shares during the period. Geode Capital Management LLC lifted its position in shares of Bath & Body Works by 2.3% during the first quarter. Geode Capital Management LLC now owns 4,725,145 shares of the company’s stock worth $172,450,000 after purchasing an additional 106,263 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Bath & Body Works by 23.8% in the first quarter. Bank of America Corp DE now owns 3,696,733 shares of the company’s stock valued at $135,226,000 after purchasing an additional 709,500 shares during the period. 94.31% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. Barclays raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $41.00 to $45.00 in a research note on Tuesday, August 1st. Citigroup lifted their target price on Bath & Body Works from $38.00 to $40.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 16th. Telsey Advisory Group reissued an “outperform” rating and issued a $52.00 price target on shares of Bath & Body Works in a report on Wednesday, August 23rd. UBS Group raised their price objective on Bath & Body Works from $38.00 to $39.00 and gave the company a “neutral” rating in a research note on Thursday, August 24th. Finally, 51job reaffirmed a “maintains” rating on shares of Bath & Body Works in a research report on Monday, May 22nd. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $46.69.
Bath & Body Works Price Performance
NYSE:BBWI opened at $36.10 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $30.52 and a 12-month high of $49.55. The business has a 50 day simple moving average of $36.73 and a 200 day simple moving average of $36.70. The firm has a market capitalization of $8.21 billion, a P/E ratio of 11.76, a P/E/G ratio of 1.24 and a beta of 1.74.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, August 23rd. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.07. The firm had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Bath & Body Works had a net margin of 9.47% and a negative return on equity of 30.08%. Bath & Body Works’s revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.52 EPS. Research analysts anticipate that Bath & Body Works, Inc. will post 3.1 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 1st. Stockholders of record on Friday, August 18th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend was Thursday, August 17th. Bath & Body Works’s dividend payout ratio (DPR) is 26.06%.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
- Five stocks we like better than Bath & Body Works
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
- Are Penny Stocks a Good Fit for Your Portfolio?
- Got Nuclear? Three Stocks To Play Energy’s Next Frontier
- What Does Downgrade Mean in Investing?
- The Top 4 Utilities for Value, Yield, and Upside Potential
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.